Bacterin International Holdings, Inc. (BONE) Reports Positive First Clinical Results for OsteoSponge SC Product
Bacterin International Holdings develops, manufactures, and markets biologics products, such as bone graft material and antimicrobial coatings, worldwide. The company's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair, and dermal growth. These products are used in a wide variety of surgeries. The company announced today that the first clinical results using the OsteoSponge SC product for regeneration of subchondral bone in complex lesions of the talus involving advanced subchondral bone damage have been published in the peer-reviewed journal, Foot & Ankle Specialist. The article reported on six…